Next Article in Journal
Dulaglutide Ameliorates Intrauterine Adhesion by Suppressing Inflammation and Epithelial–Mesenchymal Transition via Inhibiting the TGF-β/Smad2 Signaling Pathway
Next Article in Special Issue
Radioligand Therapy with [177Lu]Lu-DOTA-TATE or [177Lu]Lu-DOTA-TATE and [90Y]Y-DOTA-TATE in Patients with Neuroendocrine Neoplasms of Unknown Locations, or Locations Other Than the Midgut and Pancreas as Primaries in a G1, G2 and G3 Grade
Previous Article in Journal
Discovery of RC-752, a Novel Sigma-1 Receptor Antagonist with Antinociceptive Activity: A Promising Tool for Fighting Neuropathic Pain
Previous Article in Special Issue
Demonstration of the Early Cardiac Bioavailability of a Non-Specific Cell-Targeted Peptide Using Radionuclide-Based Imaging In Vivo
 
 
Communication

Article Versions Notes

Pharmaceuticals 2023, 16(7), 963; https://doi.org/10.3390/ph16070963
Action Date Notes Link
article xml file uploaded 5 July 2023 12:29 CEST Original file -
article xml uploaded. 5 July 2023 12:29 CEST Update https://www.mdpi.com/1424-8247/16/7/963/xml
article pdf uploaded. 5 July 2023 12:30 CEST Version of Record https://www.mdpi.com/1424-8247/16/7/963/pdf
article html file updated 5 July 2023 12:31 CEST Original file -
article html file updated 5 July 2023 12:32 CEST Update -
article html file updated 20 July 2023 20:40 CEST Update https://www.mdpi.com/1424-8247/16/7/963/html
Back to TopTop